Table 6.
EN | PN | EA | PA | SA | ||||
---|---|---|---|---|---|---|---|---|
Boys in community sample, 14+ years old (Wave 3); n = 645 | ||||||||
Percentiles | 10 | 5 | 5 | 5 | 5 | 5 | ||
50 | 6 | 5 | 6 | 5 | 5 | |||
60 | 7 | 6 | 6 | 5 | 5 | |||
70 | 8 | 6 | 7 | 5 | 5 | |||
80 | 9 | 9* | 9* | 5 | 5 | |||
90 | 12* | 9* | 10* | 7 | 5 | |||
95 | 15** | 11** | 12* | 8* | 5 | |||
96 | 15** | 12** | 13** | 9* | 6* | |||
97 | 17** | 13*** | 13** | 10** | 8** | |||
98 | 18*** | 13*** | 14** | 13*** | 13*** | |||
99 | 20*** | 15*** | 18*** | 17*** | 15*** | |||
Boys in community sample, 17 years old (Wave 5); n = 415 | ||||||||
Percentiles | 10 | 5 | 5 | 5 | 5 | 5 | ||
50 | 6 | 5 | 5 | 5 | 5 | |||
60 | 7 | 6 | 6 | 5 | 5 | |||
70 | 9 | 6 | 7 | 5 | 5 | |||
80 | 10* | 8* | 8 | 5 | 5 | |||
90 | 12* | 9* | 10* | 6 | 5 | |||
95 | 14* | 11** | 12* | 7 | 5 | |||
96 | 15** | 11** | 12* | 8* | 5 | |||
97 | 17** | 12** | 13** | 9* | 6* | |||
98 | 17** | 13*** | 14** | 10** | 7* | |||
99 | 23*** | 14*** | 17*** | 15*** | 14*** | |||
Boys in clinical sample, 14-25 years old (mean 18); n = 45 | ||||||||
Percentiles | 10 | 5 | 5 | 5 | 5 | 5 | ||
50 | 8 | 6 | 7 | 5 | 5 | |||
60 | 10* | 6 | 8 | 5 | 5 | |||
70 | 12* | 8* | 8 | 5 | 5 | |||
80 | 13* | 11** | 10* | 6 | 5 | |||
90 | 17** | 14*** | 13** | 7 | 6* | |||
95 | 20*** | 17*** | 18*** | 10** | 12** | |||
96 | 21*** | 17*** | 19*** | 11** | 15*** | |||
97 | 23*** | 18*** | 21*** | 12** | 18*** | |||
Girls in community sample, 14+ years old (Wave 3); n = 659 | ||||||||
Percentiles | 10 | 5 | 5 | 5 | 5 | 5 | ||
50 | 6 | 5 | 6 | 5 | 5 | |||
60 | 7 | 5 | 6 | 5 | 5 | |||
70 | 8 | 6 | 7 | 5 | 5 | |||
80 | 9 | 7 | 9* | 5 | 5 | |||
90 | 12* | 9* | 11* | 6 | 5 | |||
95 | 15** | 10** | 13** | 8* | 5 | |||
96 | 15** | 10** | 13** | 8* | 5 | |||
97 | 16** | 11** | 14** | 9* | 5 | |||
98 | 17** | 12** | 16*** | 10** | 7* | |||
99 | 19*** | 13*** | 18*** | 11** | 12* | |||
Girls in community sample, 17 years old (Wave 5); n =520 | ||||||||
Percentiles | 10 | 5 | 5 | 5 | 5 | 5 | ||
50 | 6 | 5 | 6 | 5 | 5 | |||
60 | 6 | 5 | 6 | 5 | 5 | |||
70 | 8 | 6 | 7 | 5 | 5 | |||
80 | 9 | 7 | 8 | 5 | 5 | |||
90 | 11* | 9* | 10* | 5 | 5 | |||
95 | 14* | 10** | 13** | 6 | 6* | |||
96 | 14* | 10** | 13** | 7 | 7* | |||
97 | 15** | 11** | 15** | 8* | 7* | |||
98 | 16** | 11** | 15** | 9* | 8** | |||
99 | 18*** | 13*** | 18*** | 10** | 12** | |||
Girls in clinical sample, 14-25 years old (mean 18); n = 29 | ||||||||
Percentiles | 10 | 5 | 5 | 5 | 5 | 5 | ||
50 | 9 | 7 | 8 | 5 | 5 | |||
60 | 11* | 8* | 12* | 5 | 5 | |||
70 | 12* | 9* | 13** | 6 | 5 | |||
80 | 14* | 10** | 15** | 8* | 9** | |||
90 | 19*** | 15*** | 22*** | 12** | 19*** | |||
95 | 20*** | 18*** | 24*** | 17*** | 24*** | |||
96 | 20*** | 19*** | 24*** | 18*** | 24*** |